Evidence map›Paper›PMID 42225547›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026

Organelle-Resolved Tetrazine-trans-Cyclooctene Click Chemistry for Cargo Delivery and Release.

Oleh Durydivka, Marek Chovanec, Rastislav Dzijak, Michal Rahm, Jachym Hrusak, Paul E Reyes-Gutierrez, Milan Vrabel

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oleh DurydivkaDepartment of Bioorganic and Medicinal Chemistry, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.ORCID https://orcid.org/0000-0001-9206-4092
Marek ChovanecDepartment of Bioorganic and Medicinal Chemistry, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.ORCID https://orcid.org/0000-0003-4378-7934
Rastislav DzijakDepartment of Bioorganic and Medicinal Chemistry, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.
Michal RahmDepartment of Bioorganic and Medicinal Chemistry, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.
Jachym HrusakDepartment of Bioorganic and Medicinal Chemistry, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.
Paul E Reyes-GutierrezDepartment of Bioorganic and Medicinal Chemistry, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-6325-8936
Milan VrabelDepartment of Bioorganic and Medicinal Chemistry, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.ORCID https://orcid.org/0000-0001-6633-4351

Funding

Academy of Sciences of the Czech Republic 61388963European UnionNational Institute for Research of Metabolic and Cardiovascular Diseases LX22NPO5104New Technologies for Translational Research in Pharmaceutical Sciences /NETPHARM CZ.02.01.01/00/22_008/0004607
6 · The paper itself

Abstract

Accurate delivery of small molecules to specific cell compartments or organelles offers great potential for bioimaging and targeted therapy but remains challenging to predict and control. In this study, we evaluate a modular strategy for organelle-directed delivery based on organelle-targeting groups combined with tetrazine-trans-cyclooctene bioorthogonal chemistry. We demonstrate that organelle-targeting probes bearing tetrazine or trans-cyclooctene can efficiently undergo inverse-electron-demand Diels-Alder reactions within various cellular compartments, including the plasma membrane, mitochondria, nucleus, endoplasmic reticulum, and lysosomes. Using this method, we localize fluorophores and the cytotoxic drug doxorubicin to specific organelles in living cells. We further show that tetrazine- or trans-cyclooctene-modified doxorubicin prodrugs restore cytotoxic activity upon click-to-release activation inside cells. However, direct comparisons of different probe architectures revealed that organelle targeting and reaction efficiency are highly sensitive to structural context, cargo type, and subcellular environment, and cannot be predicted solely from targeting motifs. Overall, these findings establish a framework for comparing organelle-targeted bioorthogonal chemistry and offer practical guidance for designing probes and prodrugs that enable precise spatiotemporal control of small-molecule activity in living cells.

Indexed as

CyclooctanesDoxorubicinOrganellesProdrugsAza CompoundsBenzene DerivativesClick ChemistryCycloaddition ReactionDrug Delivery SystemsFluorescent DyesHumansMitochondria1,2,4,5-tetrazineAza CompoundsBenzene DerivativesCyclooctanesDoxorubicinFluorescent DyesProdrugsclick chemistrydoxorubicindrug deliveryinverse‐electron‐demand Diels‐Alder reactionlive‐cell imagingorganelle targeting

Identifiers

PMID42225547
PMCPMC13587637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.